BIOSIMILARS

Molecule (Brand) Marketed Indications Development Pre-Clinical Clinical Launch
Teriparatide (Forteo/Forsteo) Osteoporosis Check Mark Check Mark Check Mark Check Mark
Denosumab (Prolia/Xgeva) Osteoporosis, Cancer-Related Indications Check Mark Check Mark Check Mark Check Mark
Romiplostim (N-Plate) Chronic Idiopathic Thrombocytopenic Purpura Check Mark Check Mark Check Mark Check Mark
Cetuximab (Erbitux) Metastatic Colorectal Cancer, Head &
Neck Cancer		 Check Mark Check Mark Check Mark
Adalimumab (Humira) Rheumatoid Arthritis, Ulcerative Colitis,
Crohn's Disease, etc.		 Check Mark Check Mark Check Mark
Bevacizumab (Avastin) Metastatic Colorectal Cancer, Non-Small
Cell Lung Cancer		 Check Mark Check Mark Check Mark
Ranibizumab (Lucentis) Wet Age-Related Macular Degeneration Check Mark Check Mark
Liraglutide (Victoza) Type 2 Diabetes Check Mark Check Mark
Tocilizumab (Actemra) Rheumatoid Arthritis Check Mark
Pertuzumab (Perjeta) Cancer-Related Indications Check Mark